We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The therapy is significantly close to glucose metabolism improvement achieved with gastric bypass surgery in obese and type 2 diabetes patients, company claims. Read More
The clinical trial will evaluate the company’s first-of-its-kind dual therapy stent, which was developed to repair vessel injury and regenerate endothelium. Read More